Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
The Prostate
|
September 7, 2006
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer
John T Isaacs, Roberto Pili, David Z Qian, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
October 12, 2005
Implications of emerging risk factors for therapeutic intervention
Gerd Assmann, Paul Cullen, Jean-Charles Fruchart, et al.
Journal for Immunotherapy of Cancer
|
December 18, 2015
Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment
Anders Olsson, Jessica Nakhlé, Anette Sundstedt, et al.
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society
|
September 29, 2020
Management of diastasis of the rectus abdominis muscles: recommendations for swedish national guidelines
Anders Carlstedt, Sven Bringman, Mattias Egberth, et al.
New Biotechnology
|
July 17, 2021
Fed-batch production assessment of a tetravalent bispecific antibody: A case study on piggyBac stably transfected HEK293 cells
Antonino Napoleone, Ida Laurén, Triinu Linkgreim, et al.
Cancer Research
|
November 15, 2012
Tasquinimod Is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironment
John T Isaacs, Lizamma Antony, Susan L Dalrymple, et al.
Cell Chemical Biology
|
January 24, 2018
Lipids Shape the Electron Acceptor-Binding Site of the Peripheral Membrane Protein Dihydroorotate Dehydrogenase
Joana Costeira-Paulo, Joseph Gault, Gergana Popova, et al.
Nature Communications
|
November 5, 2024
A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice
Aman Mebrahtu, Ida Laurén, Rosanne Veerman, et al.
Cancer Immunology Research
|
November 6, 2014
Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models
Li Shen, Anette Sundstedt, Michael Ciesielski, et al.
Open Biology
|
May 10, 2023
Caprin-1 binding to the critical stress granule protein G3BP1 is influenced by pH
Tim Schulte, Marc D Panas, Xiao Han, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
The Prostate
|
September 7, 2006
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer
John T Isaacs, Roberto Pili, David Z Qian, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
October 12, 2005
Implications of emerging risk factors for therapeutic intervention
Gerd Assmann, Paul Cullen, Jean-Charles Fruchart, et al.
Journal for Immunotherapy of Cancer
|
December 18, 2015
Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment
Anders Olsson, Jessica Nakhlé, Anette Sundstedt, et al.
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society
|
September 29, 2020
Management of diastasis of the rectus abdominis muscles: recommendations for swedish national guidelines
Anders Carlstedt, Sven Bringman, Mattias Egberth, et al.
New Biotechnology
|
July 17, 2021
Fed-batch production assessment of a tetravalent bispecific antibody: A case study on piggyBac stably transfected HEK293 cells
Antonino Napoleone, Ida Laurén, Triinu Linkgreim, et al.
Cancer Research
|
November 15, 2012
Tasquinimod Is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironment
John T Isaacs, Lizamma Antony, Susan L Dalrymple, et al.
Cell Chemical Biology
|
January 24, 2018
Lipids Shape the Electron Acceptor-Binding Site of the Peripheral Membrane Protein Dihydroorotate Dehydrogenase
Joana Costeira-Paulo, Joseph Gault, Gergana Popova, et al.
Nature Communications
|
November 5, 2024
A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice
Aman Mebrahtu, Ida Laurén, Rosanne Veerman, et al.
Cancer Immunology Research
|
November 6, 2014
Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models
Li Shen, Anette Sundstedt, Michael Ciesielski, et al.
Open Biology
|
May 10, 2023
Caprin-1 binding to the critical stress granule protein G3BP1 is influenced by pH
Tim Schulte, Marc D Panas, Xiao Han, et al.
Page
of 5